HC Wainwright & Co. Maintains Buy on NovaBridge Biosciences, Raises Price Target to $9

NovaBridge Biosciences +17.04% Pre

NovaBridge Biosciences

NBP

3.64

3.64

+17.04%

0.00% Pre
HC Wainwright & Co. analyst Andres Y. Maldonado maintains NovaBridge Biosciences (NASDAQ: NBP) with a Buy and raises the price target from $7 to $9.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via